Executives On The Move: Moderna Names Senior Vice-President Of Government Engagement
Affimed, FibroGen And Redx Pharma Get New Board Members
Oasmia Pharmaceutical and Sierra Oncology appoint chief business officers, I-Mab a chief commercial officer, and AcuCort a CEO.
You may also be interested in...
Moderna led by releasing the trial protocol for its COVID-19 vaccine study, followed by Pfizer, as industry faces demands for transparency.
Plus promotions at Agios Pharmaceuticals, Bafna Pharmaceuticals, Miragen Therapeutics and Compass Therapeutics.
Plus: Valneva confirms supply deal with the UK government for its inactivated vaccine candidate; Humanigen expands manufacturing ahead of Phase III data.